Data Knights Acquisition Corp.

We intend to focus our search on industries that complement our management team’s background and to capitalize on the ability of our management team to identify and acquire a business focusing on the data centers and internet technology sectors where our management team has extensive experience. (Note: Data Knights Acquisition Corp. priced its SPAC IPO […]

May 6, 2021 Read More

Angel Pond Holdings Corp.

We intend to focus on target businesses within the Greater China region, especially on companies within technology-enabled sectors, including but not limited to: e-commerce, enterprise software and cloud computing, and FinTech. (Incorporated in the Cayman Islands) Simon Xie, a co-founder of Alibaba Group, is a co-founder of Angel Pond Holdings Corp.  The SPAC’s other co-founder is Theodore […]

Read More

B. Riley Principal 250 Merger Corp.

We intend to focus on established businesses that have an aggregate enterprise value of approximately $800 million to $2 billion and would benefit from access to public markets and the operational and strategic expertise of our management team and board of directors. We will seek to capitalize on the significant experience of our management team in consummating […]

Read More

Enact Holdings, Inc. (formerly Genworth Mortgage Holdings, Inc.)

(Note: Genworth Financial revived its Enact Holdings spin-off’s IPO in early August with a new underwriting lineup and filed terms in an S-1/A filing dated Sept. 13, 2021. Genworth Financial is the selling stockholder; Genworth is offering all of the 13.31 million shares in the IPO. Enact Holdings will not receive any of the IPO […]

Read More

Anebulo Pharmaceuticals, Inc.

We are a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. Our lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis […]

May 5, 2021 Read More

SimilarWeb Ltd.

SimilarWeb provides a leading platform for digital intelligence, delivering a trusted, comprehensive and detailed view of the digital world that empowers our customers to be competitive in their markets. Our proprietary technology analyzes billions of digital interactions and transactions every day from millions of websites and apps, and turns these digital signals into actionable insights. […]

May 4, 2021 Read More

Global-E Online Ltd.

Global-e’s mission is to make global e-commerce “border-agnostic” – Go global. Be local. We have built the world’s leading platform to enable and accelerate global, direct-to-consumer (“D2C”) cross-border e-commerce. (Global-E Online Ltd. is incorporated in Israel.) Our platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from, and to, anywhere in the world – in short, […]

Read More

Alfi, Inc. (common)

We provide solutions that bring transparency and accountability to the digital out of home, or “DOOH,” advertising marketplace. Alfi uses artificial intelligence and big data analytics to measure and predict human response. Our computer vision technology is powered by proprietary artificial intelligence, to determine the age, gender, ethnicity, geolocation and emotion of someone in front […]

Read More

Waterdrop Inc.

Our Mission: We at Waterdrop aspire to bring insurance and healthcare service to billions through technology. (Note: Incorporated in the Cayman Islands) Overview: We are a leading technology platform dedicated to insurance and healthcare service with a positive social impact. We are the largest independent third-party insurance platform in China in terms of life and health insurance […]

May 3, 2021 Read More

Gyroscope Therapeutics Holdings plc

We are a global clinical-stage gene therapy company developing gene therapy beyond rare diseases. Our mission is to preserve sight and fight the devastating impact of blindness. Our science is grounded in the genetic understanding of patients with serious eye diseases to make medicines designed to have a meaningful impact. Our initial focus is age-related macular degeneration, […]

Read More
Page 188 of 307« First...102030...186187188189190...200210220...Last »